Resmetirom Reduces Liver, CV Risk Factors in NASH With Cirrhosis ...Middle East

Medscape - News
After 1 year of therapy with the oral thyromimetic, patients with well-compensated NASH cirrhosis had significant improvements in both liver- and heart-related risk factors. Medscape Medical News

Hence then, the article about resmetirom reduces liver cv risk factors in nash with cirrhosis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Resmetirom Reduces Liver, CV Risk Factors in NASH With Cirrhosis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News